子宫内膜异位症相关不孕干预措施的系统综述与网络荟萃分析
该系统综述与网络荟萃分析纳入36项随机对照试验,其中26项试验涉及2245名经腹腔镜确诊的子宫内膜异位症相关不孕女性。网络荟萃分析显示,与安慰剂相比,单纯腹腔镜手术(OR=1.63;95%CI 1.13-2.35)或单纯GnRH激动剂(OR=1.68;95%CI 1.07-2.46)与更高的妊娠几率相关。其他干预措施及活产、流产、不良事件等结局的证据不足,需更多随机对照试验明确相对有效性。
要点
- 与安慰剂相比,单纯腹腔镜手术或GnRH激动剂可提高子宫内膜异位症相关不孕患者的妊娠几率。
- 其他干预措施及活产、流产、不良事件等结局的证据不足。
- 需更多随机对照试验比较干预措施与现有推荐方案(如腹腔镜手术)及IVF/IUI。
核心结论
- 与安慰剂相比,单纯腹腔镜手术或单纯GnRH激动剂与更高的妊娠几率相关。
- 其他干预措施及活产、流产、不良事件等结局的证据不足。
- 需更多随机对照试验明确各种治疗方案的相对有效性。
研究设计与样本
- 系统综述与随机对照试验的网络荟萃分析。
- 文献检索共识别4252项试验/摘要,系统综述纳入36项试验。
- 网络荟萃分析纳入26项试验,报告2245名子宫内膜异位症相关不孕女性的数据。
- 研究对象为经腹腔镜确诊的子宫内膜异位症相关不孕女性。
主要发现
- 与安慰剂相比,单纯腹腔镜手术的妊娠几率OR=1.63(95%CI 1.13-2.35)。
- 与安慰剂相比,单纯GnRH激动剂的妊娠几率OR=1.68(95%CI 1.07-2.46)。
- 其他干预措施对比安慰剂的证据不足。
- 活产、流产和不良事件等次要结局的证据不足。
关键数值与推荐
- 单纯腹腔镜手术 vs 安慰剂:妊娠OR=1.63(95%CI 1.13-2.35)。
- 单纯GnRH激动剂 vs 安慰剂:妊娠OR=1.68(95%CI 1.07-2.46)。
临床怎么用
- 对于子宫内膜异位症相关不孕女性,可考虑单纯腹腔镜手术或GnRH激动剂以改善妊娠几率。
- 其他干预措施的疗效尚不明确,临床决策需结合个体情况。
- 需更多随机对照试验比较不同干预措施与现有推荐方案及IVF/IUI的效果。
局限性
- 其他干预措施及活产、流产、不良事件等结局的证据不足。
- 需更多随机对照试验明确治疗的相对有效性。
- 需进一步比较IVF和IUI与其他干预措施的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effectiveness of different treatments for women with endometriosis-related infertility. DESIGN: A systematic review and network meta-analysis of randomized controlled trials (RCTs). SETTING: Not applicable. PATIENT(S): Women with endometriosis confirmed by laparoscopy with associated infertility. INTERVENTION(S): An extensive electronic search of the following databases: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, ClinicalTrials.gov, and Embase. MAIN OUTCOME MEASURE(S): Clinical pregnancy, live birth rate, miscarriage, and adverse events. RESULT(S): A total of 4,252 trials/abstracts were identified through the literature search, of which we included 36 trials in the systematic review and 26 trials reporting on 2,245 women with endometriosis-related infertility in the network meta-analysis. Network meta-analysis showed that compared with placebo, surgical laparoscopy alone (odds ratio = 1.63; 95% confidence interval, 1.13-2.35) or GnRH agonist alone (odds ratio = 1.68; 95% confidence interval, 1.07-2.46) results in higher odds of pregnancy. The evidence on the other interventions versus placebo or on the secondary outcomes including live birth, miscarriage, and adverse events is insufficient. CONCLUSION(S): The most important conclusion is that more RCTs are needed to clarify the relative effectiveness of treatments for endometriosis-related infertility, ideally comparing interventions to existing recommended interventions such as surgical laparoscopy. In addition, further RCTs comparing IVF and IUI to other treatments are essential. REGISTRATION NUMBER: PROSPERO registration number, CRD42018087572.
引用
- Hodgson RM, Lee HL, Wang R, et al. Interventions for endometriosis-related infertility: a systematic review and network meta-analysis. Fertil Steril. 2020. PMID: 32106991. doi:10.1016/j.fertnstert.2019.09.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。